Page 61 - Read Online

Saier et al. J Cancer Metastasis Treat 2021;7:43 https://dx.doi.org/10.20517/2394-4722.2021.87 Page 23 of 24

adenocarcinomas correlates with high differentiation. Cancer Res 2007;67:9190-8. DOI PubMed
164. Tornhamre S, Stenke L, Granzelius A, et al. Inverse relationship between myeloid maturation and leukotriene C4 synthase expression
in normal and leukemic myelopoiesis-consistent overexpression of the enzyme in myeloid cells from patients with chronic myeloid
leukemia. Exp Hematol 2003;31:122-30. DOI PubMed
165. Ali HEA, Lung PY, Sholl AB, et al. Dysregulated gene expression predicts tumor aggressiveness in African-American prostate
cancer patients. Sci Rep 2018;8:16335. DOI PubMed PMC
166. Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjölander A. Leukotriene D(4) activates MAPK through a Ras-independent but
PKCepsilon-dependent pathway in intestinal epithelial cells. J Cell Sci 2002;115:1883-93. PubMed
167. Mezhybovska M, Wikström K, Ohd JF, Sjölander A. The inflammatory mediator leukotriene D4 induces beta-catenin signaling and
its association with antiapoptotic Bcl-2 in intestinal epithelial cells. J Biol Chem 2006;281:6776-84. DOI PubMed
168. Massoumi R, Nielsen CK, Azemovic D, Sjölander A. Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin
E2 and upregulation of α2β1-integrin. Exp Cell Res 2003;289:342-51. DOI PubMed
169. Salim T, Sand-Dejmek J, Sjölander A. The inflammatory mediator leukotriene D4 induces subcellular β-catenin translocation and
migration of colon cancer cells. Exp Cell Res 2014;321:255-66. DOI PubMed
170. Chen X, Li N, Wang S, et al. Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of
bestatin. J Natl Cancer Inst 2003;95:1053-61. DOI PubMed
171. Zhao S, Yao K, Li D, et al. Inhibition of LTA4H by bestatin in human and mouse colorectal cancer. EBioMedicine 2019;44:361-74.
DOI PubMed PMC
172. Tong WG, Ding XZ, Talamonti MS, Bell RH, Adrian TE. LTB4 stimulates growth of human pancreatic cancer cells via MAPK and
PI-3 kinase pathways. Biochem Biophys Res Commun 2005;335:949-56. DOI PubMed
173. Ihara A, Wada K, Yoneda M, Fujisawa N, Takahashi H, Nakajima A. Blockade of leukotriene B4 signaling pathway induces
apoptosis and suppresses cell proliferation in colon cancer. J Pharmacol Sci 2007;103:24-32. DOI PubMed
174. Kim H, Choi JA, Kim JH. Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a
leukotriene B4 receptor-2-linked cascade in mammary epithelial cells. J Biol Chem 2014;289:22151-60. DOI PubMed PMC
175. Tian W, Jiang X, Sung YK, et al. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to
Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation. Circulation
2019;140:1409-25. DOI PubMed PMC
176. Chheda ZS, Sharma RK, Jala VR, Luster AD, Haribabu B. Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor
Immunity by Facilitating CD8+ T Cell Migration into Tumors. J Immunol 2016;197:2016-26. DOI PubMed PMC
177. Edelman MJ, Watson D, Wang X, et al. Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive
predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203. J Clin Oncol 2008;26:848-55. DOI
PubMed
178. Jänne PA, Paz-Ares L, Oh Y, et al. Randomized, double-blind, phase II trial comparing gemcitabine-cisplatin plus the LTB4
antagonist LY293111 versus gemcitabine-cisplatin plus placebo in first-line non-small-cell lung cancer. J Thorac Oncol 2014;9:126-
31. DOI PubMed
179. Tsai MJ, Wu PH, Sheu CC, et al. Cysteinyl leukotriene receptor antagonists decrease cancer risk in asthma patients. Sci Rep
2016;6:23979. DOI PubMed PMC
180. Gunning WT, Kramer PM, Steele VE, Pereira MA. Chemoprevention by lipoxygenase and leukotriene pathway inhibitors of vinyl
carbamate-induced lung tumors in mice. Cancer Res 2002;62:4199-201. PubMed
181. Nozaki M, Yoshikawa M, Ishitani K, et al. Cysteinyl leukotriene receptor antagonists inhibit tumor metastasis by inhibiting capillary
permeability. Keio J Med 2010;59:10-8. DOI PubMed PMC
182. Jose MA, Amathi R, Sathyamurthy D, Kumar BN. Chemopreventive effect of montelukast in n-nitroso n-methyl urea induced
mammary carcinogenesis in female Sprague-Dawley rats. Indian J Pharmacol 2013;45:286-8. DOI PubMed PMC
183. Savari S, Liu M, Zhang Y, Sime W, Sjölander A. CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer.
PLoS One 2013;8:e73466. DOI PubMed PMC
184. Satapathy SR, Sjölander A. Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in
colon cancer cells. Cancer Lett 2020;488:50-62. DOI PubMed
185. Tumber A, Morgan HM, Meikle MC, Hill PA. Human breast-cancer cells stimulate the fusion, migration and resorptive activity of
osteoclasts in bone explants. Int J Cancer 2001;91:650-3. DOI PubMed
186. Poczobutt JM, Nguyen TT, Hanson D, et al. Deletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer
Progression and Metastasis through Regulating T Cell Recruitment. J Immunol 2016;196:891-901. DOI PubMed PMC
187. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45. DOI PubMed
188. Fishbein A, Wang W, Yang H, et al. Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated
hepatocellular cancer progression. Proc Natl Acad Sci U S A 2020;117:21576-87. DOI PubMed PMC
189. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, O’Reilly MS. Radiation therapy to a primary tumor accelerates
metastatic growth in mice. Cancer Res 2001;61:2207-11. PubMed
190. Chang J, Bhasin SS, Bielenberg DR, et al. Chemotherapy-generated cell debris stimulates colon carcinoma tumor growth via
osteopontin. FASEB J 2019;33:114-25. DOI PubMed PMC
191. Filippou PS, Karagiannis GS. Cytokine storm during chemotherapy: a new companion diagnostic emerges? Oncotarget 2020;11:213-
5. DOI PubMed PMC
192. Gartung A, Yang J, Sukhatme VP, et al. Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a